IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease

40Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Interleukin-2 (IL-2) and IL-15 are structurally related cytokines that share receptor components but display markedly different effects in multiple in vivo model systems. Here we demonstrate that IL-15 but not IL-2 exacerbates xenogeneic graft-versus-host disease (X-GVHD) in severe combined immunodeficient murine recipients of human peripheral-blood lymphocytes (hu-PBL-SCID). Treatment of hu-PBL-SCID mice with IL-15 resulted in rapid fatality, lymphocytic infiltrations in the liver, lung, and spleen consistent with X-GVHD, and a marked expansion of human CD4+ and CD8+ T cells compared with controls. Depletion of human T cells in vivo abrogated the lethality of IL-15 treatment. To our knowledge, these data are the first to demonstrate in vivo activation and expansion of human T lymphocytes in response to IL-15 with concomitant exacerbation of human T-cell-mediated X-GVHD. © 2005 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Roychowdhury, S., Blaser, B. W., Freud, A. G., Katz, K., Bhatt, D., Ferketich, A. K., … Caligiuri, M. A. (2005). IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease. Blood, 106(7), 2433–2435. https://doi.org/10.1182/blood-2005-04-1597

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free